Updates
Red Mail
29°
Tel Aviv-Jaffa
Search
Main
Israel News
Mideast & World News
Tech & Digital
Real Estate
Finance
Lifestyle
Health & Science
Jewish World
Travel
More
Channels
Opinions
Magazine
Sports
Food
Weather
Podcasts
Sites & Sources
Ynet
Calcalist
yad2
ynetespanol
Вести
mynet
Contact
Contact us
Privacy Policy
Terms of Use
Accessibility Statement
main
Israel News
Mideast & World News
Tech & Digital
Real Estate
Finance
Lifestyle
Health & Science
Jewish World
Travel
29°
Weather
YnetGlobal Channels
Opinions & Analysis
Magazine
Food
Sports
Weather
Podcasts
Sites & Sources
ynet
calcalist
yad2
Español
Вести
mynet
more channels
Israel News
Mideast & World News
Tech & Digital
Finance
Lifestyle
Health & Science
Travel
Contact
Contact us
Privacy Policy
Terms of Use
Accessibility Statement
Tags
FDA
FDA approves breakthrough drug for metastatic pancreatic cancer: 'A real revolution'
After decades of efforts to block the tumor-driving RAS protein, the FDA approved daraxonrasib after unprecedented survival gains in metastatic pancreatic cancer; treatment costs about NIS 90,000 a month, raising access concerns
Eitan Gefen
|
08.27.26
For the first time, new blood test can help detect Alzheimer’s from age 40
A new FDA-approved blood test could help detect Alzheimer’s from age 40 by measuring proteins linked to brain amyloid; intended for people with cognitive decline, it showed high predictive accuracy and is due in the US later this year
Tzur Gueta
|
08.24.26
Symptoms improved within first week: FDA approves new ADHD drug for children, adults
Simtriyo, the first approved ADHD drug to inhibit norepinephrine, dopamine and serotonin reuptake, improved symptoms within a week; US launch depends on controlled-substance classification, and it is not yet available in Israel
Tzur Gueta
|
08.02.26
FDA approves first cholesterol pill to match powerful injectable drugs
Merck’s once-daily Lipfendra offers a pill alternative to injectable cholesterol drugs after Phase 3 trials involving Israeli patients
Daniel Edelson, New York
|
07.17.26
FDA approves breast cancer drug that cut progression risk by 76%
Revtorpyk was approved for women with advanced breast cancer whose disease worsened after previous hormone-based treatments; patients receiving the three-drug combination went a median 9.3 months without progression, compared with two months on standard therapy alone
Reuters
|
07.15.26
FDA approves long-used sunscreen already sold in Israel and Europe after 25-year delay
A sunscreen ingredient that has been used in Europe and Asia since 2000 and is already found in products sold in Israel has been officially approved for use in the US; It protects against UVA and UVB, is photostable and highlights US lag in sunscreen regulation
News Agencies
|
06.11.26
FDA reverses course on Moderna flu vaccine after White House meeting
A week after declining to review Moderna’s new flu vaccine, the FDA reversed course; Politico reported the shift followed a White House meeting between Trump and the agency chief, amid a broader fight over mRNA vaccines under Health Secretary Robert F. Kennedy Jr.
News Agencies
|
02.19.26
Can a pig liver save a failing human one?
As FDA-approved trials begin, researchers are testing whether a genetically engineered pig liver used outside the body can filter blood like a biological dialysis machine, giving the human liver time to rest, recover or await transplant
Tzur Gueta
|
02.10.26
FDA approves Aidoc’s first-of-its-kind AI triage platform for emergency and outpatient imaging
Powered by a single foundation model, the newly cleared solution integrates 14 acute conditions into one workflow, aiming to speed diagnoses, reduce imaging backlogs and improve patient safety in both emergency departments and ambulatory care
ynet Global
|
01.22.26
Sex after 65: FDA approves libido-boosting pill for women
US regulators expand approval of Addyi to postmenopausal women; experts say treatment for low sexual desire remains complex, with limited effectiveness and side effects
Tzur Gueta
|
12.17.25
Can Israeli medtech grow in the US without relocating? At least one firm plans to help
US-based The Mullings Group opens Israel office, aiming to accelerate Israeli medtech companies’ path to FDA clearance, commercialization and US market scale without forcing founders to relocate
Maayan Hoffman/The Media Line
|
12.17.25
FDA plans unusual warning on COVID vaccines; experts sharply criticize move
Agency considering adding a black box warning to COVID vaccines over claims of child deaths, according to CNN; critics say data are undisclosed, process lacks transparency and decision appears politically driven
ynet Global
|
12.12.25
Israeli startup QuantalX wins FDA clearance for first-of-its-kind brain function assessment system
The Delphi-MD system, combining magnetic stimulation and EEG, offers real-time, non-invasive brain health insights and sets new US regulatory standard; already in use in Israel and top US research centers, device now being deployed commercially
ynet Global
|
11.22.25
Israeli at-home ultrasound tech firm Pulsenmore soars 33% after winning FDA approval
Tel Aviv-based Pulsenmore, developer of the world’s first home ultrasound device for pregnant women, surged 33% after receiving FDA clearance to market its product, paving the way for entry into the American market
Navit Zomer
|
11.02.25
Trump administration to link covid shots to child deaths, alarming scientists
Trump officials plan to cite unverified reports tying COVID-19 vaccines to 25 child deaths at a CDC advisory meeting, alarming scientists who warn the shots are safe and protect against severe illness
Ynet Global
|
09.12.25
More Articles
Hot Tags
Today
This Week
This Month
AI
AI agents
Amazon Prime
Antisemitism
Apple TV+
Arab Israelis
Artificial Intelligence
assassination attempt
Band
Benjamin Netanyahu
Hot Tags
Today
This Week
This Month
AI
AI agents
Amazon Prime
Antisemitism
Apple TV+
Arab Israelis
Artificial Intelligence
assassination attempt
Band
Benjamin Netanyahu
Related Tags
AI
alchemiq
Artificial Intelligence
Cancer
Women
Brain
medicine
Vaccination
Sex
Vaccine
""